Publication
Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe
| dc.contributor.author | Kissling, Esther | |
| dc.contributor.author | Rondy, Marc | |
| dc.contributor.author | I-MOVE/I-MOVE+ study team | |
| dc.date.accessioned | 2018-03-02T11:46:11Z | |
| dc.date.available | 2018-03-02T11:46:11Z | |
| dc.date.issued | 2017-02-16 | |
| dc.description | I-MOVE/I-MOVE+ study team: Portugal - Baltazar Nunes, Ausenda Machado, Ana Paula Rodrigues, Verónica Gomez, Irina Kislaya, Mafalda Sousa Uva (Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge); Raquel Guiomar, Pedro Pechirra, Paula Cristóvão, Patrícia Conde, Inês Costa (Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Doutor Ricardo Jorge). | pt_PT |
| dc.description | I-MOVE/I-MOVE+study team - Portugal: Baltazar Nunes, Departamento de Epidemiologia, Instituto Nacional de Saúde Dr. Ricardo Jorge; Ausenda Machado, Departamento de Epidemiologia, Instituto Nacional de Saúde Dr. Ricardo Jorge; Ana Paula Rodrigues, Departamento de Epidemiologia, Instituto Nacional de Saúde Dr. Ricardo Jorge; Verónica Gomez, Departamento de Epidemiologia, Instituto Nacional de Saúde Dr. Ricardo Jorge; Irina Kislaya, Departamento de Epidemiologia, Instituto Nacional de Saúde Dr. Ricardo Jorge; Mafalda Sousa Uva, Departamento de Epidemiologia, Instituto Nacional de Saúde Dr. Ricardo Jorge; Raquel Guiomar, Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Dr. Ricardo Jorge; Pedro Pechirra, Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Dr. Ricardo Jorge; Paula Cristóvão, Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Dr. Ricardo Jorge; Patrícia Conde, Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Dr. Ricardo; Jorge Inês Costa, Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Dr. Ricardo Jorge. | |
| dc.description.abstract | We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0-14, 15-64 and ≥ 65 year-olds, and 25.7% in the influenza vaccination target group. At hospital level, IVE was 2.5%, 7.9% and 2.4% among ≥ 65, 65-79 and ≥ 80 year-olds. As in previous seasons, we observed suboptimal IVE against influenza A(H3N2). | pt_PT |
| dc.description.sponsorship | This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634446. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Euro Surveill. 2017 Feb 16;22(7). pii: 30464. doi: 10.2807/1560-7917.ES.2017.22.7.30464 | pt_PT |
| dc.identifier.doi | 10.2807/1560-7917.ES.2017.22.7.30464 | pt_PT |
| dc.identifier.issn | 1560-7917 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/5125 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | European Centre for Disease Prevention and Control | pt_PT |
| dc.relation | I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly | |
| dc.relation.publisherversion | http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2017.22.7.30464 | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | pt_PT |
| dc.subject | Case-Control Studies | pt_PT |
| dc.subject | Europe | pt_PT |
| dc.subject | Influenza A Virus, H3N2 Subtype | pt_PT |
| dc.subject | Influenza Vaccines | pt_PT |
| dc.subject | Population Surveillance | pt_PT |
| dc.subject | Primary Health Care | pt_PT |
| dc.subject | Vaccination | pt_PT |
| dc.subject | Influenza Like illness | pt_PT |
| dc.subject | Cuidados de Saúde | pt_PT |
| dc.subject | Infecções Respiratórias | |
| dc.title | Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly | |
| oaire.awardURI | info:eu-repo/grantAgreement/EC/H2020/634446/EU | |
| oaire.citation.issue | 7 | pt_PT |
| oaire.citation.startPage | pii: 30464 | pt_PT |
| oaire.citation.title | Eurosurveillance | pt_PT |
| oaire.citation.volume | 22 | pt_PT |
| oaire.fundingStream | H2020 | |
| project.funder.identifier | http://doi.org/10.13039/501100008530 | |
| project.funder.name | European Commission | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isProjectOfPublication | ccfd73a6-6f3c-4702-956c-544973bca97d | |
| relation.isProjectOfPublication.latestForDiscovery | ccfd73a6-6f3c-4702-956c-544973bca97d |